We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Meeting the Growing Need for Heroin Addiction Treatment

Richard S. Schottenfeld, MD1,2; Stephanie S. O’Malley, PhD1,2
[+] Author Affiliations
1Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut
2Connecticut Mental Health Center, New Haven
JAMA Psychiatry. 2016;73(5):437-438. doi:10.1001/jamapsychiatry.2016.0139.
Text Size: A A A
Published online


In this issue of JAMA Psychiatry, Oviedo-Joekes et al1 report the results of a single-site randomized noninferiority clinical trial in Vancouver, British Columbia, Canada, showing that supervised injection of hydromorphone hydrochloride is not inferior to supervised injection of heroin (diacetylmorphine hydrochloride) in long-term injection street opioid users. Supervised injection of diacetylmorphine (the active ingredient in heroin) and flexible doses of methadone hydrochloride had been previously evaluated compared with oral methadone treatment for those who had failed methadone maintenance.2 These studies found that supervised diacetylmorphine injection was effective in improving retention in treatment and reducing illicit drug use, incarceration, and criminal offenses. Because diacetylmorphine is not available in most countries, the study by Oviedo-Joekes et al1 sought to determine whether supervised injection of hydromorphone could provide an alternative to diacetylmorphine. The study results indicate that for an important, but small and carefully defined population, supervised injection of hydromorphone has comparable efficacy to supervised heroin injection when both are provided in structured, well-staffed medical programs.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles